Daewoong Bio Inc., an independent affiliate of the Daewoong Group based in Seoul, South Korea, was company founded in 1983. Daewoong Bio produces cGMP complaint world-class products under quality guarantee systems. As a key manufacturer, Daewoong Bio provides APIs for global distribution and to multinational corporations developing original products.

Daewoong Bio is also a full-service pharmaceutical company that utilizes our internal R&D, production facilities, and experienced marketing force with external global networks. Daewoong Bio is specialized to produce both world-class antibiotic APIs and general APIs.

Presently, Daewoong Bio is implementing an ambitious strategic plan to develop a complete line of carbapenems at a dedicated cGMP facility.

As a major API provider in Asia, Daewoong Bio is currently expanding business into Western pharmaceutical markets. Through improved production facilities and adherence to rigorous cGMP standards, our new cGMP manufacturer plant will become a top API producer in South Korea as well as establishing Daewoong Bio as an important global supplier of API for advanced pharmaceutical markets in North America, Europe, and Japan.